Literature DB >> 1370277

Prognostic B-cell epitopes on the flagellar protein of Borrelia burgdorferi.

T Schneider1, R Lange, W Rönspeck, W Weigelt, H W Kölmel.   

Abstract

Overlapping decapeptides based on the flagellin sequence of Borrelia burgdorferi B31 (G. S. Gassmann, M. Kramer, U. B. Göbel, and R. Wallich, Nucleic Acids Res. 17:3590, 1989) were used to identify immunologically reactive regions of flagellin. Five serum specimens from patients with late manifestations of Lyme disease and borrelia-specific monoclonal antibody H9724 reacted with an epitope in the central region of the flagellar protein (amino acids 205 to 226), which is heterologous to the amino acid sequences of other bacterial flagellins. This epitope was not recognized by human sera with antibodies to Treponema pallidum, sera of healthy individuals, or sera from patients with stage I or II of Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370277      PMCID: PMC257539          DOI: 10.1128/iai.60.1.316-319.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene.

Authors:  R Wallich; S E Moter; M M Simon; K Ebnet; A Heiberger; M D Kramer
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Antibodies to myelin basic protein in Lyme disease.

Authors:  J C Garcia-Monco; J L Coleman; J L Benach
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

3.  Western immunoblot and flagellum enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis.

Authors:  M Karlsson
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

4.  Analysis of the Borrelia burgdorferi GeHo fla gene and antigenic characterization of its gene product.

Authors:  G S Gassmann; E Jacobs; R Deutzmann; U B Göbel
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

5.  Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.

Authors:  T Schneider; H P Harthus; P Hildebrandt; M Niedrig; M Bröker; W Weigelt; A Beck; G Pauli
Journal:  AIDS Res Hum Retroviruses       Date:  1991-01       Impact factor: 2.205

6.  Immunoreactive epitopes on an expressed recombinant flagellar protein of Borrelia burgdorferi.

Authors:  C Collins; G Peltz
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

7.  Cells secreting antibodies to myelin basic protein in cerebrospinal fluid of patients with Lyme neuroborreliosis.

Authors:  S Baig; T Olsson; B Höjeberg; H Link
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

8.  Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue.

Authors:  E Aberer; C Brunner; G Suchanek; H Klade; A Barbour; G Stanek; H Lassmann
Journal:  Ann Neurol       Date:  1989-12       Impact factor: 10.422

9.  Improved immunoglobulin M serodiagnosis in Lyme borreliosis by using a mu-capture enzyme-linked immunosorbent assay with biotinylated Borrelia burgdorferi flagella.

Authors:  K Hansen; K Pii; A M Lebech
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

10.  Validity of western immunoblot band patterns in the serodiagnosis of Lyme borreliosis.

Authors:  L Zöller; S Burkard; H Schäfer
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  9 in total

1.  Analysis of the humoral response to the flagellin protein of Borrelia burgdorferi.

Authors:  T Schneider; R Lange; W Weigelt
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

2.  Immunoglobulin M capture assay for serologic confirmation of early Lyme disease: analysis of immune complexes with biotinylated Borrelia burgdorferi sonicate enhanced with flagellin peptide epitope.

Authors:  M Brunner; S Stein; P D Mitchell; L H Sigal
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

3.  Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato.

Authors:  B Wilske; V Fingerle; V Preac-Mursic; S Jauris-Heipke; A Hofmann; H Loy; H W Pfister; D Rössler; E Soutschek
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

4.  Serologic analysis of dogs, horses, and cottontail rabbits for antibodies to an antigenic flagellar epitope of Borrelia burgdorferi.

Authors:  E Fikrig; L A Magnarelli; M Chen; J F Anderson; R A Flavell
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

5.  Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis.

Authors:  L A Magnarelli; E Fikrig; R Berland; J F Anderson; R A Flavell
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

6.  Mapping the major antigenic domains of the native flagellar antigen of Borrelia burgdorferi.

Authors:  W Jiang; B J Luft; W Schubach; R J Dattwyler; P D Gorevic
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

7.  Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis.

Authors:  M J Mathiesen; M Christiansen; K Hansen; A Holm; E Asbrink; M Theisen
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

8.  Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line.

Authors:  E Fikrig; R Berland; M Chen; S Williams; L H Sigal; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

9.  Identification of conserved antigens for early serodiagnosis of relapsing fever Borrelia.

Authors:  Job E Lopez; Stephen F Porcella; Merry E Schrumpf; Sandra J Raffel; Carl H Hammer; Ming Zhao; Mary Ann Robinson; Tom G Schwan
Journal:  Microbiology (Reading)       Date:  2009-05-14       Impact factor: 2.777

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.